Related Experiment Videos
Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in the human gene
H Puy1, A M Robréau, R Rosipal
1Centre Français des Porphyries, INSERM U409, Hôpital Louis Mourier, Colombes, France.
Biochemical and Biophysical Research Communications
|September 4, 1996
Summary
Variegate porphyria (VP) is a heme synthesis disorder linked to protoporphyrinogen oxidase (PPOX) deficiency. This study details the complete human PPOX gene sequence and its variations, aiding in understanding VP pathogenesis.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Variegate porphyria (VP) is an autosomal dominant disorder affecting heme synthesis.
- It results from a partial deficiency in protoporphyrinogen oxidase (PPOX).
- Previous research involved sequencing human PPOX cDNA, gene cloning, and chromosomal assignment to 1q23.
Purpose of the Study:
- To report the complete nucleotide sequence of the human PPOX gene.
- To characterize the exon/intron organization and promoter region of the PPOX gene.
- To identify sequence variations within the PPOX gene.
Main Methods:
- Gene sequencing
- Bioinformatic analysis
- Characterization of gene structure and variations
Main Results:
- The complete nucleotide sequence of the human PPOX gene, including 660 bp of its promoter region, was determined.
- The PPOX gene spans 5.5 kb with introns ranging from 84 bp to 507 bp.
- Two exonic and three intronic biallelic sequence variations were identified.
Conclusions:
- The complete sequence and organization of the human PPOX gene are now characterized.
- Identified sequence variations provide a basis for further genetic studies of VP.
- This detailed genetic information is crucial for understanding VP molecular mechanisms.